Q301--NEW - Karius Next Generation Sequencing Test B+3
ID: 36C25725Q0270Type: Special Notice
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF257-NETWORK CONTRACT OFFICE 17 (36C257)ARLINGTON, TX, 76006, USA

NAICS

Medical Laboratories (621511)

PSC

MEDICAL- LABORATORY TESTING (Q301)

Original Source

https://sam.gov/opp/80d74bcc22b649d787a4437212f70815/view
Timeline
    Description

    The Department of Veterans Affairs (VA) is planning to award a firm-fixed-price contract to Karius, Inc. for the provision of the Karius Test®, a next-generation sequencing blood test designed to detect over 1,000 pathogens through microbial cell-free DNA analysis. This contract aims to enhance the rapid diagnosis and treatment of infections, particularly for immunocompromised patients, within the Texas Valley Coastal Bend Health Care System (TVCBHCS) in Harlingen, TX. The Karius Test® is recognized for its non-invasive nature and high diagnostic accuracy, making it a critical tool in the VA's healthcare offerings. Interested parties may submit capability statements within 10 days of this notice's publication; however, if no affirmative responses are received, the contract will be awarded to Karius, Inc. For further inquiries, interested firms should contact Ognian Ivanov at ognian.ivanov@va.gov or (210) 620-1571.

    Point(s) of Contact
    Ognian IvanovContract Specialist
    (210) 620-1571
    ognian.ivanov@va.gov
    Files
    Title
    Posted
    36C25725Q0270.docx
    The Department of Veterans Affairs (VA) plans to award a firm-fixed-price contract to Karius, Inc. for providing the Karius Test®, a next-generation blood test for detecting over 1,000 pathogens through microbial cell-free DNA analysis. This service will specifically cater to the Texas Valley Coastal Bend Health Care System (TVCBHCS) in Harlingen, TX. Karius, Inc. is identified as the exclusive source for this test, with the procurement being justified under 41 U.S.C. 3304(a)(1) due to the unavailability of equivalent alternatives. This notice serves as a call for capability statements from interested parties who may want to offer similar services, with a response deadline set for 10 days post-publication. If there are no affirmative responses, the contract will proceed to Karius, Inc. There are additional instructions regarding communications with the point of contact and the absence of a solicitation for proposals or quotations. The document reinforces the VA's adherence to regulatory frameworks while ensuring access to unique medical testing services for veterans.
    SOW Karius Test.docx
    The Texas Valley Coastal Bend Health Care System (TVCBHCS) seeks to contract Karius Next Generation Sequencing testing to enhance the rapid diagnosis and treatment of infections, particularly in immunocompromised patients. The Karius test is notable for its non-invasive nature and high diagnostic accuracy, identifying over 1,000 pathogens from a plasma sample. The contractor is responsible for specimen transportation, testing, analysis, and timely reporting of results, ensuring compliance with CLIA standards and offering communication channels for status inquiries. Security and confidentiality of patient data are paramount, requiring contractors to adhere to strict HIPAA regulations and undergo background checks. The contract spans from April 1, 2025, to March 31, 2029, with provisions for quality control, testing methodology changes, and thorough documentation of test results. Compliance with information security protocols and regular audits will be essential for safeguarding sensitive patient information. This engagement reflects the VA's commitment to utilizing innovative technologies for improving healthcare outcomes while maintaining stringent security and confidentiality standards.
    Lifecycle
    Title
    Type
    Q301--NEW - Karius Next Generation Sequencing Test B+3
    Currently viewing
    Special Notice
    Similar Opportunities
    6550--MRSA Molecular Microbiology
    Buyer not available
    The Department of Veterans Affairs, specifically the Network Contracting Office 22, is seeking qualified vendors for MRSA Molecular Microbiology services under a Sources Sought Notice. The procurement aims to enhance clinical laboratory capabilities across various VA facilities, requiring advanced analyzers that comply with CLIA and CLSI standards, along with a continuous supply of high-quality reagents for testing infectious agents and cancer markers. This initiative is crucial for improving healthcare delivery to veterans, ensuring that the VA can meet rising medical testing demands effectively. Interested parties must submit their capabilities and relevant information by February 12, 2025, to Carlos Magana at carlos.magana@va.gov, with the solicitation number 36C26225Q0407 guiding the process.
    Q301--Biodesix, Inc. (621 II) (PENDING PROPOSAL)
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for reference laboratory services under the Federal Supply Schedule (FSS) program, specifically for medical laboratory testing related to disease diagnosis and patient health assessment. The procurement aims to establish contracts for services that comply with federal, state, and local regulations, including necessary licensing and accreditation, while ensuring that only new items are provided and that grey market goods are strictly prohibited. This opportunity is critical for enhancing the quality of healthcare services provided to veterans, with a focus on compliance with the Trade Agreements Act and other regulatory requirements. Interested vendors should contact Contract Specialist Brian O'Connell at Brian.O'connell@va.gov for further details, and they must adhere to the submission deadlines outlined in the solicitation documents.
    6640--FY 25 Short Term Emergency Contract Molecular Random Access Analyzer
    Buyer not available
    The Department of Veterans Affairs intends to award a sole-source contract for a Short Term Emergency procurement of a Molecular Random Access Analyzer, specifically the Cepheid GeneXpert Infinity Reagents and Consumables. This procurement is being conducted under FAR 13.5 Simplified Procedures for Certain Commercial Items, emphasizing the need for efficient acquisition of critical laboratory equipment. The selected vendor must demonstrate technical capability to fulfill the requirements, with responses due by January 17, 2025, at 2:00 PM Eastern Time, submitted to Contract Specialist Darrin Alexander at darrin.alexander2@va.gov. The statutory authority for this procurement is U.S.C. § 1901, and the relevant NAICS code is 334516, which pertains to Analytical Laboratory Instrument Manufacturing.
    6640--New - VCB Automation Line Bridge
    Buyer not available
    The Department of Veterans Affairs, specifically the Veterans Health Administration's Network Contracting Office 17, intends to award a sole source contract to Abbott Laboratories, Inc. for the procurement of essential supplies and services related to immunochemistry testing. This contract will cover the acquisition of reagents, consumables, and the rental of three analyzers, along with maintenance services, to support the Pathology and Laboratory Medicine Service at VA laboratories located in McAllen, Harlingen, and Corpus Christi, Texas. The supplies and services are critical for ongoing medical evaluations, including a wide range of tests detailed in an accompanying inventory document, which highlights the demand for various assays. Interested parties may submit capability statements to the contracting officer, Delphia Schoenfeld, at delphia.schoenfeld@va.gov within seven business days of this notice, as the contract is expected to be awarded to Abbott Laboratories if no competitive proposals are received.
    6640--NEW CBOC LAB EQUIPMENT Lease
    Buyer not available
    The Department of Veterans Affairs is seeking qualified vendors to lease laboratory equipment for the Oscar G Johnson VA Medical Center's Community Based Outreach Clinics (CBOCs) located in Michigan and Wisconsin. The procurement aims to acquire FDA-approved point-of-care analyzers and assays capable of simultaneously detecting SARS-CoV-2, RSV, and Influenza A & B from nasal swab specimens. This initiative is part of the government's efforts to enhance health services at multiple clinic locations, ensuring timely and accurate testing for critical respiratory viruses. Interested vendors must submit their responses, including company information and pricing details, by February 5, 2025, and are reminded to register in the System for Award Management (SAM) to comply with federal requirements. For inquiries, vendors can contact Contract Specialist Teresa Beers at teresa.beers@va.gov or call 414-844-4865.
    6630--V16 Lab Chemistry and Immunochemistry CPRR BPA (VA-25-00010416)
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Quotation (RFQ) for a Blanket Purchase Agreement (BPA) focused on Chemistry and Immunochemistry instrumentation and testing for the South Central VA Health Care Network (VISN 16). This procurement aims to standardize automated equipment across 8 medical center and 20 outpatient laboratories, ensuring compliance with the 1988 Clinical Laboratory Improvement Act and FDA approval for all reagents, while also providing operator training and 24/7 repair services. The initiative underscores the VA's commitment to enhancing laboratory capabilities through modern technology, with site visits permitted until February 28, 2025, allowing vendors to assess laboratory conditions and align their offerings with specific site requirements. Interested contractors can contact Diyonne Williams, the Contracting Officer, at Diyonne.Williams@va.gov for further information.
    VISN 1 Primary Reference Laboratory Testing
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for VISN 1 Primary Reference Laboratory Testing Services, aimed at enhancing laboratory testing capabilities for veterans' healthcare facilities across New England. The contract encompasses a comprehensive range of services, including specimen collection, transportation, analytical testing, and timely reporting of results, all in compliance with federal and state regulations. This initiative is crucial for ensuring efficient healthcare delivery to veterans, facilitating access to necessary diagnostic services. Interested contractors should note that the contract period is from April 1, 2025, to September 30, 2025, with options for extension, and are encouraged to contact Cynthia Thompson at Cynthia.Thompson2@va.gov or Sheryl Anthony at Sheryl.anthony@va.gov for further details.
    Q301--Amendment to Post Technical Q's and Extend Closing Date - NTX Reference Lab Testing
    Buyer not available
    The Department of Veterans Affairs, through the Network Contracting Office 17, is seeking proposals for laboratory testing services at the VA North Texas Health Care System in Dallas, Texas. The procurement aims to secure a contractor capable of providing a wide range of laboratory tests with established turnaround times, ensuring compliance with quality standards and federal regulations, including HIPAA. This initiative is critical for delivering reliable healthcare resources to veterans, with an estimated contract value of $41.4 million over five years, commencing on May 15, 2025. Interested vendors must submit their proposals by February 13, 2025, at 3:00 PM CST, and can direct inquiries to Senior Contract Specialist Jose Campa at Jose.Campa@va.gov or (210) 694-6311.
    6640--STVHCS - Automated Blood Bank Analyzer - Cost Per Test
    Buyer not available
    The Department of Veterans Affairs (VA) intends to award a sole source contract to Ortho-Clinical Diagnostics for an Automated Blood Bank Analyzer under a Cost Per Test agreement. This procurement includes essential components such as the Ortho Vision Analyzer, external drain kit, keyboard, and various supplies necessary for the analyzer's operation and maintenance, along with training for operators. The decision for a sole source procurement is based on the justification that Ortho-Clinical is the only vendor capable of providing a direct replacement for the existing analyzer, ensuring the continuity of critical services within the South Texas Veterans Health Care System. Interested parties may submit capability statements for consideration, and the primary contact for this opportunity is Contract Specialist Joshua Weisman, who can be reached at joshua.weisman@va.gov or (432) 213-7094.
    Microbial Testing Supplies - Bridge Contract
    Buyer not available
    The Department of Defense, specifically the Department of the Army, is seeking to award a sole-source bridge contract for microbial testing supplies to Biomerieux Inc., covering the period from October 1, 2024, to September 30, 2025. This procurement is essential for the William Beaumont Army Medical Center Laboratory, as it involves leasing a microbial identification analyzer and a mass spectrometer, along with necessary reagents and middleware/server interface provision. The unique requirements for ATO authorization on DHA networks necessitate this sole-source approach, as Biomerieux is the only contractor capable of meeting these needs without service disruption. Interested parties can contact Troy Loge at troy.a.loge.civ@health.mil or Robyn Villafranco at Robyn.A.Villafranco.civ@health.mil for further details, with the total contract value estimated at $213,334.67.